WAe001-A-85

H1.0102, H1.0-102

General

Cell Line

hPSCreg name WAe001-A-85
Cite as:
WAe001-A-85 (RRID:CVCL_C9JU)
Alternative name(s)
H1.0102, H1.0-102
Cell line type Human embryonic stem cell (hESC)
Similar lines
WAe001-A-96
(H1X-10/H1.0-31, H1X10/H1.031)
WAe001-A-83
(H1.0-29, H1.029)
WAe001-A-97
(H1X-59/H1.0-19, H1X59/H1019)
WAe001-A
(WA01, H1)
WAe001-A-A
(H1X-10/H1.2-20)
WAe001-A-2B
(H1-NSD2-/-)
WAe001-A-B
(H1X-59/H1.2-6)
WAe001-A-C
(H1X-10/H1.3-62)
WAe001-A-D
(H1X-59/H1.3-68)
WAe001-A-E
(H1X-10/H1.4-4)
WAe001-A-F
(H1X-59/H1.4-5)
WAe001-A-86
(H1.139, H1.1-39)
WAe001-A-72
(H1-FTO-Knockout-13)
WAe001-A-31
(H1_RB1ex1_D6)
WAe001-A-32
(H1_RB1ex1_E9)
WAe001-A-87
(H1.213, H1.2-13)
WAe001-A-G
(H1X-10/H1.5-1)
WAe001-A-88
(H1.2-124, H1.2124)
WAe001-A-1N
(H1-FIS1-KO, WA01-FIS1-KO)
WAe001-A-89
(H1.3-64, H1.364)
WAe001-A-H
(H1X-59/H1.5-33)
WAe001-A-1O
(WA01-MYB-KO, H1-MYB-KO)
WAe001-A-77
(H1 RYBP-FLAG-HA KI)
WAe001-A-90
(H1.3-191, H1.3191)
WAe001-A-I
(H1.0-29/H1.1-13)
WAe001-A-41
(H1-RNF2-KO-1#)
WAe001-A-J
(H1.0-102/H1.1-34)
WAe001-A-42
(H1-RNF2-KO-2#)
WAe001-A-K
(H1.0-29/H1.2-31)
WAe001-A-1
(H1.1, WA01.1)
WAe001-A-L
(H1.0-102/H1.2-6)
WAe001-A-M
(H1.0-29/H1.3-22)
WAe001-A-N
(H1.0-102/H1.3-90)
WAe001-A-91
(H1.4-126, H1.4126)
WAe001-A-O
(H1.0-29/H1.4-14)
WAe001-A-92
(H1.4-143, H1.4143)
WAe001-A-P
(H1.0-102/H1.4-19)
WAe001-A-93
(H1.5-23, H1.523)
WAe001-A-78
(H1X10, H1X-10)
WAe001-A-94
(H1.528, H1.5-28)
WAe001-A-Q
(H1.0-29/H1.5-6)
WAe001-A-73
(H1-GATAD2B-KO-79#)
WAe001-A-R
(H1.0-102/H1.5-44)
WAe001-A-10
(H1_RB1ex3_G3)
WAe001-A-74
(H1-GATAD2B-KO-81#)
WAe001-A-S
(H1.1-17/H1.2-11)
Last update 31st August 2022
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.

Provider

Generator King Abdullah University of Science and Technology (KAUST)
Owner King Abdullah University of Science and Technology (KAUST)
Distributors
Derivation country Saudi Arabia

External Databases

BioSamples SAMEA111265304
Cellosaurus CVCL_C9JU
Wikidata Q123033814

General Information

* Is the cell line readily obtainable for third parties?
No
Subclone of

Donor Information

General Donor Information

Sex male
Ethnicity N/A

Phenotype and Disease related information (Donor)

Diseases No disease was diagnosed.
Disease associated phenotypes no phenotypes
Family history NO
Is the medical history available upon request? NO
Is clinical information available? NO

Karyotyping (Donor)

Has the donor karyotype been analysed?
Yes
46, XY
Karyotyping method: G-Banding

Other Genotyping (Donor)

Is there genome-wide genotyping or functional data available?
No

Donor Relations

Other cell lines of this donor
All cell lines of this donor's relatives

External Databases (Donor)

BioSamples SAMEA7767418

Ethics

Also have a look at the ethics information for the parental line WAe001-A .
Is there an MTA available for the cell line? No
Are you aware of any constraints on the use or distribution of the cell line from the owner or any parties identified in the query above? No

hESC Derivation

The source cell information can be found in the parental cell line WAe001-A.

Culture Conditions

Surface coating Laminin
Feeder cells
No
Passage method Enzymatically
Accutase
CO2 Concentration 5 %
Medium Essential 8™
Has Rock inhibitor (Y27632) been used at passage previously with this cell line?
Yes
Has Rock inhibitor (Y27632) been used at cryo previously with this cell line?
Yes
Has Rock inhibitor (Y27632) been used at thaw previously with this cell line?
Yes

Characterisation

Analysis of Undifferentiated Cells
Marker Expressed Immunostaining RT-PCR Flow Cytometry Enzymatic Assay Expression Profiles
SOX2
Yes
NANOG
Yes
OCT4
Yes
OCT3
Yes
Morphology pictures
Differentiation Potency
Endoderm
Ont Id: UBERON_0000925
In vitro directed differentiation
Marker Expressed
FOXA2
Yes
SOX17
Yes
Protocol or reference
differentiation protocol.pdf
differentiation protocol
Mesoderm
Ont Id: UBERON_0000926
In vitro directed differentiation
Marker Expressed
Brachyury
Yes
NCAM
Yes
Ectoderm
Ont Id: UBERON_0000924
In vitro directed differentiation
Marker Expressed
Nestin
Yes
SOX1
Yes
CD44
Yes

Genotyping

Karyotyping (Cell Line)

Has the cell line karyotype been analysed?
Yes
46, XY
Passage number: +13
Karyotyping method: G-Banding

Other Genotyping (Cell Line)

Genetic Modification

Genetic modifications not related to a disease
H1.0 (target)
Gene knock-out
Chromosome 22: 37,805,229-37,807,432
Knock-out was genotyped by Sanger sequencing, RT-qPCR, and Western blot to confirm the absence of the sequence/protein.
CRISPR-associated (CRISPR/Cas) System
H1.0-102 genotyping.pdf
Knock-out confirmation